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Objectives: Surgical decision making for patients with early hepatocellular carcinoma (HCC) and well-
compensated cirrhosis remains controversial. The aim of the current study was to conduct a meta-
analysis of published reports to compare survival outcomes after transplantation and resection,
respectively, in patients with early HCC [i.e. HCC falling within the Milan Criteria (a solitary lesion
measuring 5 cm or fewer than three lesions with a largest diameter of 3 cm, and absence of
macroscopic vascular invasion or extrahepatic disease)] and well-compensated cirrhosis.
Methods: A total of 990 abstracts were identified through a PubMed-based search. Ten articles com-
paring transplantation and resection in patients with early HCC were included in the meta-analysis.
Meta-analysis was performed using STATA 9.2 statistical software.
Results: Outcomes were analysed for a total of 1763 patients with early HCC. The 5-year overall survival
(OS) for all patients was 58% (transplantation: 63%; resection: 53%). Meta-analysis of all 10 studies
revealed a survival advantage for transplantation [odds ratio (OR) 0.581, 95% confidence interval (CI)
0.359–0.939; P = 0.027]. Analysis of only those reports that utilized an ‘intention-to-treat’ strategy failed
to demonstrate a survival advantage for either treatment approach (OR 0.600, 95% CI 0.291–1.237;
P = 0.166).
Conclusions: The current study demonstrates a favourable outcome in patients with early HCC treated
by either transplantation or resection. Although transplantation was noted to have a survival advantage in
some settings, resection continues to be a viable treatment approach.
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Introduction
Worldwide, hepatocellular carcinoma (HCC) is the fifth most
common cancer, with an estimated 748 300 new cases diagnosed
in 2008, and is also a leading cause of mortality, accounting for an
estimated 695 900 cancer deaths in 2008.1 Although HCC is much
more frequent in eastern Asia, its incidence continues to rise in
the United States (US) as a result of major risk factors such as
hepatitis C virus (HCV)-induced cirrhosis and non-alcoholic ste-
atohepatitis (NASH).1–3 In 2011, an estimated 26 190 new cases
and 19 590 deaths from liver and intrahepatic bile duct cancers
were expected in the US.4
Several treatment options are available to patients with HCC
and the ideal option is determined based on the burden of tumour
and extent of underlying liver disease.5,6 Transplantation and
resection remain the major therapeutic options available to
patients with HCC.5–7 Patients with early-stage disease [i.e. HCC
falling within the Milan Criteria (a solitary lesion measuring
5 cm or up to three lesions with a largest diameter of 3 cm,
and absence of macroscopic vascular invasion or extrahepatic
disease)] and advanced cirrhosis, including Child–Pugh class B/C
disease and portal hypertension, are thought to be candidates
for transplantation, whereas resection remains the treatment of
choice in patients without underlying liver disease. However,
significant controversy exists regarding the choice between trans-
plantation and resection in the management of patients with
well-compensated cirrhosis (i.e. patients with Child–Pugh class A
disease and selected patients with class B disease) and early HCC.
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Recently published studies from the Western hemisphere have
added to the controversy by demonstrating the superiority of
transplantation in one study and that of resection in the other.8,9
Lastly, it is also known that the specialty of the surgeon and his or
her expertise can influence the chosen treatment approach.10
Resection is available immediately, but is associated with recur-
rent disease, whereas outcomes after transplantation may be com-
promised by waiting times secondary to organ shortage. Because
of this delay in organ availability, a subset of patients [approxi-
mately 10% (range: 0–30%) of patients at 6 months11] with early
HCC, who are listed for transplantation, experience disease
progression and ultimately succumb to the disease. Therefore,
to determine true outcomes after transplantation, patients who
demonstrate disease progression while on the waiting list (and
become unsuitable for transplantation or die during waiting)
should be included in the analysis. This type of analysis to deter-
mine overall outcomes after transplantation, which includes
dropouts, is called an ‘intention-to-treat’ (ITT) analysis and was
initially performed by Llovet et al.12
Most previous studies comparing outcomes after transplanta-
tion with those after resection have used a heterogeneous group of
patients that included patients with different stages of underlying
liver disease. These studies failed to limit the analysis to patients
with early HCC and well-compensated cirrhosis and did not
utilize an ITT strategy. Thus, because of the contradictory nature
of the published evidence, the ideal treatment approach for
patients with early HCC and well-compensated cirrhosis remains
undetermined.
The aim of the current study was to perform a meta-analysis to
compare overall survival (OS) following transplantation and
resection, respectively, in patients with early HCC and well-
compensated cirrhosis (Child–Pugh classes A and B in the absence
of portal hypertension) using an ITT strategy.
Materials and methods
Search strategy and inclusion and exclusion criteria
The PubMed database was searched for articles published in
English between January 1990 and March 2011 using the key
words ‘hepatocellular carcinoma’ AND ‘resection’ AND ‘trans-
plantation’. A total of 990 articles were identified. The abstracts of
the 990 articles were reviewed to identify relevant articles. An
extensive backward search was performed using the bibliogra-
phies of relevant articles and review articles to ensure that the
search was comprehensive. Figure 1 depicts the search strategy in
detail.
The following articles were excluded from the analysis:
1 review articles and letters;
2 articles reporting outcomes in HCC after resection or trans-
plantation alone;
3 articles comparing primary vs. salvage liver transplant;
4 articles comparing resection with non-resectional therapies;
5 articles primarily reporting the outcomes of non-resectional
therapies;
6 articles including patients with non-cirrhotic HCCs, fibrola-
mellar HCCs and hepatocholangio carcinomas, and
7 articles that compared patients with no evidence of cirrhosis
treated by resection with cirrhotic patients who underwent
transplantation.
The following articles were included in the meta-analysis:
1 articles comparing OS in patients with HCC and cirrhosis
undergoing transplantation vs. resection;
2 articles that reported 5-year OS percentages, and
3 articles that reported on samples of patients with tumours
within the Milan Criteria (early HCC; solitary lesion measuring
5 cm or no more than three lesions with a largest diameter of
3 cm; absence of macroscopic vascular invasion and extrahe-
patic disease).
The full texts of 85 articles were reviewed. Of these, 24 articles
were identified as comparing outcomes after transplantation and
resection, respectively, in patients with HCC.12–35 A recently pub-
lished report by Koniaris et al. was excluded because its authors
had included resection patients with no evidence of cirrhosis in
their analysis.9 Similarly, a comprehensive review by Kitisin et al.
of over 1000 patients with HCC was excluded because its authors
did not specify the size of HCC and included non-cirrhotic
patients in their analysis.8
Data extraction and definitions
Estimates of the number of patients in the transplantation and
resection subcategories, respectively, and 5-year OS were extracted
from the studies (texts or tables). If a study reported 5-year OS for
all patients (i.e. for patients with disease within and outside the
Milan Criteria), only data on patients with disease within the
Milan Criteria were extracted. Similarly, if a study reported 5-year
OS data for both ITT and non-ITT analyses, only data from the
ITT analysis were extracted. Meta-analysis was performed using
the number of patients who were dead or alive, respectively, at 5
years in the transplantation and resection subgroups.
Statistical methods
Meta-analysis was performed using stataVersion 9.2 (StataCorp
LP, College Station, TX, USA). Meta-analysis was performed in
line with the Preferred Reporting Items for Systematic Reviews
and Meta-analysis (PRISMA) statement.36 All data were treated as
binary (dead vs. alive at 5 years; transplantation vs. resection). An
estimate of the number of patients who survived 5 years was
calculated by multiplying the total number of patients in the
transplantation and resection subcategories included in the study
by the corresponding 5-year OS estimate. Odds ratios (ORs) and
95% confidence intervals (CIs) computed from the binary data
were used for the final meta-analysis. Because heterogeneity
amongst the different studies was suspected, a random-effects
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model was used. Heterogeneity was explored using the chi-
squared test with a significance level of P = 0.10. I2 statistics were
calculated to further quantify heterogeneity. A meta-regression
analysis was also performed to explore the heterogeneity. Residual
maximum likelihood was used to estimate the additive (between-
study) component of variance for the meta-regression analysis.
Bootstrap analyses were performed with the Monte Carlo permu-
tation for meta-regression using 10 000 random permutations.37
Publication bias was explored using funnel plots; the symmetry of
funnel plots was analysed using objective tests such as Egger’s and
Begg’s tests to rule out any bias from the studies with small patient
samples.38,39 In order to address the questions posed by the current
meta-analysis and the issue of heterogeneity, subset analyses were
also performed for studies that included patients with well-
compensated cirrhosis, studies that utilized an ITT analysis, and
both.
Results
Literature search and description of studies
After application of the exclusion and inclusion criteria, 24 studies
that compared outcomes after transplantation and resection,
respectively, in patients with HCC were identified.12–35 Supporting
Figure 1 Flow diagram showing search strategy along with the selection and screening process for the eligible studies. HCC, hepatocellular
carcinoma
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Table S1 (online) summarizes a few important characteristics
of these 24 studies. Ten studies comparing outcomes of
transplantation with those of resection in patients with early
HCC, which reported 5-year OS, qualified for inclusion in meta-
analysis.12,14–16,21,25,26,28,30,33 Table 1 summarizes the important char-
acteristics of these 10 studies. Although Facciuto et al. compared
outcomes after transplantation and resection, respectively, in early
HCC with well-compensated cirrhosis using an ITT analysis, the
authors did not report 5-year survival rates and this study was
therefore excluded.22 All studies were retrospective in nature and
six of the 10 studies had utilized an ITT strategy for analy-
sis.12,14,16,21,28,30 Additionally, six of the 10 relevant studies had either
restricted their analysis to patients with well-compensated cirrho-
sis (i.e. patients with Child–Pugh class A disease and selected
patients with Child–Pugh class B disease) or had reported results
for patients with well-compensated cirrhosis separately.12,15,16,25,26,30
Three of the 10 relevant studies met both these criteria in that
they utilized an ITT analysis and included patients with well-
compensated cirrhosis.12,16,30
A total of 1763 patients from the 10 relevant studies were
included in the meta-analysis. The number of eligible patients per
study in the 10 studies included in the meta-analysis ranged from
37 to 379. Most studies had a mean or median follow-up of
approximately 2 years.Mean five-year OS in all patients with early
HCC (treated with transplantation or resection) was 58%
(median 57%, SE 0.108). Mean five-year OS was 63% (range:
44–78%, median 64%, SE 0.249)) in patients who underwent
transplantation, and 53% (range: 27–70%, median 56%, SE
0.324)) in patients who underwent resection.
Meta-analysis of 10 studies comparing
transplantation and resection in early HCC
Meta-analysis of the 10 studies12,14–16,21,25,26,28,30,33 comparing the
outcomes of transplantation and resection, respectively, in a total
of 1763 patients with early HCC, revealed a statistically significant
5-year survival advantage for patients undergoing transplantation
compared to resection (transplantation vs. resection, OR = 0.581,
95% CI 0.359–0.939; P = 0.027). A summary of the data and forest
plot for the estimation of effect are shown in Fig. 2. Statistically
significant between-study heterogeneity was identified (heteroge-
neity, c2 = 39.99, I2 = 77.5%, P < 0.001). Assessment of the funnel
plot (Fig. 3) ruled out any small study effects, which was con-
firmed by Egger’s test (coefficient = -1.985, 95% CI -6.588 to
2.616; P = 0.349) and Begg’s test (adj. Kendall’s score = -9,
z = -0.80, P = 0.421).
Because of the statistically significant heterogeneity amongst
the studies, a meta-regression analysis was performed to identify
factors that might account for the heterogeneity. None of the
tested variables, including sample size (P = 0.778), year of publi-
cation (P = 0.989), use of ITT analysis (P = 1.000) and well-
compensated cirrhosis (P = 0.989), were able to explain the
heterogeneity. The standard error of the P-values using a Monte
Carlo approach with 10 000 permutations was found to be 0.005.
Although the funnel plot was symmetrical overall, three studies
were found to be outliers on visual inspection.14,21,28 A subset
analysis of the other seven studies revealed a similar statistically
significant 5-year survival advantage for patients undergoing
transplantation compared to resection (transplantation vs. resec-
tion, OR = 0.516, 95% CI 0.372–0.715; P < 0.001). No significant
between-study heterogeneity was identified (heterogeneity,
c2 = 8.16, I2 = 26.5%, P = 0.227). Therefore, heterogeneity derives
mainly from these three studies.14,21,28
Meta-analysis of six studies comparing
transplantation and resection in early HCC
with well-compensated cirrhosis
Meta-analysis of the six studies12,15,16,25,26,30 comparing the out-
comes of transplantation and resection, respectively, in a total of
994 patients with early HCC and well-compensated cirrhosis
revealed a statistically significant improvement in 5-year OS in
patients with early HCC and well-compensated cirrhosis under-
going transplantation versus resection (transplantation vs. resec-
tion, OR = 0.538, 95% CI 0.377–0.766; P = 0.001). A summary of
the data and forest plot for the estimation of effect are shown in
Fig. 4. There was no statistically significant between-study hetero-
geneity (heterogeneity, c2 = 7.36, I2 = -32.1%, P = 0.195). Small
study effects were estimated to be non-significant using Egger’s
test (coefficient = -0.256, 95% CI -4.461 to 3.948; P = 0.874) and
Begg’s test (adj. Kendall’s score = 1, z = 0.19, P = 0.851).
Meta-analysis of six studies comparing
transplantation and resection in early HCC
using an ITT strategy
Meta-analysis of the six studies12,14,16,21,28,30 comparing the out-
comes of transplantation and resection, respectively, in a total of
1118 patients with early HCC, using an ITT strategy, failed to
reveal a statistically significant difference in 5-year OS between
transplantation and resection, although there was a trend towards
better 5-year OS following transplantation rather than resection
in this patient population (transplantation vs. resection, OR =
0.600, 95% CI 0.291–1.237; P = 0.166). Some of these studies
included patients with Child–Pugh class A–C cirrhosis undergo-
ing transplantation for early HCC.14,21,28 A summary of the data
and forest plot for estimation of effect are shown in Fig. 5. There
was significant between-study heterogeneity (heterogeneity, c2 =
29.95, I2 = 83.3%, P < 0.001). Again, underlying heterogeneity can
be explained by three previously mentioned studies.14,21,28 Small
study effects were estimated to be non-significant using Egger’s
test (coefficient = -4.740, 95% CI -12.066 to 2.584; P = 0.147) and
Begg’s test (adj. Kendall’s score = -7, z = -1.32, P = 0.188).
Meta-analysis of three studies comparing
transplantation and resection in early HCC with
well-compensated cirrhosis using an ITT analysis
Only three studies compared outcomes of transplantation and
resection, respectively, in early HCC with well-compensated
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Figure 2 Meta-analysis of 5-year overall survival utilizing data from 10 studies comparing outcomes after transplantation and resection,
respectively, in early hepatocellular carcinoma (i.e. within the Milan Criteria). Odds ratios (ORs) for overall survival in the transplantation and
resection subgroups were calculated using the random-effects model. The diamond represents the overall effect; squares represent the
effects for individual studies; bars indicate 95% confidence intervals (CIs)
Figure 3 Funnel plot for the 10 studies comparing outcomes after transplantation and resection, respectively, in patients with early
hepatocellular carcinoma
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cirrhosis, using an ITT strategy.12,16,30 A meta-analysis of these
three studies,12,16,30 which included a total of 412 patients, was
performed as the decision process is most controversial in this
group of patients. Meta-analysis of these studies revealed a statis-
tically significant 5-year survival advantage for patients with early
HCC and well-compensated cirrhosis undergoing transplantation
rather than resection (transplantation vs. resection, OR = 0.521,
95% CI 0.298–0.911; P = 0.022). A summary of the data and forest
plot for estimation of effect are shown in Fig. 6. Between-study
heterogeneity was not found to be statistically significant (hetero-
geneity, c2 = 2.91, I2 = 31.3%, P = 0.233). Sensitivity analysis was
not performed as only three studies qualified for meta-analysis.
Discussion
Transplantation and resection in various permutations with other
modalities, such as ablation, remain the major treatment options
available to patients with HCC. Both transplantation and resec-
tion have their own advantages and limitations.5,6 Resection is
available immediately and in carefully selected patients who are
deemed eligible, is not limited by the Milan Criteria. However,
underlying liver disease is known to preclude resection in many
patients even if they have resectable disease.5,40 Transplantation, by
contrast, removes not only the tumour but also the pre-cancerous
liver parenchyma. However, transplantation is limited by organ
shortage and allocation, which causes patients to drop out from
the waiting list. In patients with advanced liver disease, transplan-
tation is considered preferable, whereas, in patients without
underlying liver disease, resection is recommended. However, in
patients with early HCC and minimal underlying liver disease,
selection of the appropriate treatment remains controversial.
Several studies have tried to address this controversy by per-
forming a comparative analysis of outcomes after transplantation
and resection.12–35 Some of these studies are hampered by the
inclusion of patients with mismatched degrees of underlying liver
disease and varying degrees of tumour burden. Studies that
reported on resection have included patients with disease outside
the Milan Criteria or tumours with vascular invasion, both of
which inherently contribute to worse outcomes. However, the
inclusion of patients who undergo resection in the absence of any
Figure 4 Meta-analysis of 5-year overall survival utilizing data from six studies comparing outcomes after transplantation and resection,
respectively, in early hepatocellular carcinoma (i.e. within the Milan Criteria) in patients with well-compensated cirrhosis. Odds ratios (ORs)
for 5-year overall survival in the transplantation and resection subgroups were calculated using the random-effects model. The diamond
represents the overall effect; squares represent the effects for individual studies; bars indicate 95% confidence intervals (CIs)
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underlying liver disease can influence the outcomes in favour of
resection.9 Similarly, studies that have included patients with
advanced and decompensated liver disease and multiple comor-
bidities in analyses of outcomes of transplantation may have
allowed the nature of their samples to adversely influence out-
comes, whereas studies of outcomes after transplantation that
have not performed an ITT analysis will have biased outcomes in
favour of transplantation by excluding dropouts. Lastly, surgeon
specialty is also known to influence surgical decision making as
liver transplant (LT) and non-LT surgeons view various clinical
factors differently.10 Nathan et al. noted that non-LT surgeons are
more likely than LT surgeons to choose liver resection (relative
risk ratio = 2.67) for patients with early HCC.10
The aim of the current study was to address this controversy by
performing a meta-analysis to compare the outcomes of trans-
plantation and resection, respectively, in patients with early
HCC and well-compensated liver disease. Stringent criteria were
applied in the selection of studies for inclusion in the meta-
analysis. To avoid the drawbacks associated with prior compara-
tive studies, the final analysis in the present study was restricted to
a select few studies that included only early HCC patients (with
disease within the Milan Criteria) with well-compensated cirrho-
sis, and that performed an ITT analysis.
The present meta-analysis shows that in patients with early
HCC, transplantation is associated with a statistically significant
survival advantage over resection (transplantation vs. resection,
OR = 0.581, 95% CI 0.359–0.939; P = 0.027). This advantage
persisted in the subset of patients with well-compensated cirrhosis
(transplantation vs. resection, OR = 0.538, 95% CI 0.377–0.766;
P = 0.001). However, analysis of ITT studies only found no statis-
tically significant difference amongst patients undergoing trans-
plantation vs. resection (transplantation vs. resection, OR = 0.600,
95% CI 0.291–1.237; P = 0.166). Although studies that utilized
an ITT analysis and included patients with well-compensated
cirrhosis showed some survival benefit of transplantation com-
pared to resection, the numbers of such studies and patients are
small to draw any conclusions.
Any study that compares outcomes after transplantation and
resection, respectively, should utilize an ITT strategy. The concept
of ITT analysis with reference to transplantation outcomes was
first introduced by Llovet et al.12 Many patients experience disease
progression while on the waiting list and become unsuitable for
Figure 5 Meta-analysis of 5-year overall survival utilizing data from six studies comparing outcomes after transplantation and resection,
respectively, in early hepatocellular carcinoma (i.e. within the Milan Criteria), utilizing an intention-to-treat analysis. Odds ratios (ORs) for
5-year overall survival in the transplantation and resection subgroups were calculated using the random-effects model. The diamond
represents the overall effect; squares represent the effects for individual studies; bars indicate 95% confidence intervals (CIs)
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transplantation. The major predictors of dropout are: a solitary
lesion measuring >3 cm in diameter; previous hepatic resection,
and the presence of two or three tumour nodules at the time of
initial diagnosis.22,41 As Yao et al. report, dropout rates may be as
high as 25% at 1 year, but excluding these patients diminishes the
interpretive value of these studies by showing outcomes to favour
transplantation.41 Bellavance et al. conducted a multi-institution
study that compared outcomes of transplantation and resection,
respectively, in 379 patients.15 Although transplantation was noted
to be associated with better outcome (66% vs. 46%), the lack of an
ITT analysis is a major limitation of this study.15
To address the issue of ITT analysis in patients with well-
compensated cirrhosis [Model for End-stage Liver Disease
(MELD) scores of <10], Koniaris et al. performed a large, single-
institution analysis.9 In a subset ITT analysis of patients with
tumours within the Milan Criteria and MELD scores of <10, the
authors showed that the rate of 5-year OS after resection was 63%,
whereas that after transplantation was 41% (P = 0.036). Therefore,
the authors concluded that resection is associated with superior
OS and should be used as first-line therapy in these patients.9
Although these authors used an ITT analysis, they included
patients with no underlying cirrhosis in the resection group.9
Because such patients rarely meet criteria for transplantation,
these two groups are not ideal for comparison.
The current search strategy was extensive and identified only six
studies that had utilized an ITT strategy to compare outcomes
after transplantation and resection, respectively, in patients with
early HCC and reported 5-year survival in both groups of
patients.12,14,16,21,28,30 Similarly, only six studies ensured that the two
comparison groups included patients with the same extent of
underlying liver disease.12,15,16,25,26,30 Only three studies performed
an ITT analysis and used cases matched for extent of underlying
liver disease.12,16,30 This emphasizes the lack of studies that
compare outcomes after transplantation and resection, respec-
tively, in equally matched groups of patients diagnosed with HCC,
using an ITT analysis.
The present meta-analysis has several limitations. The limita-
tions of meta-analysis in general and the current meta-analysis
strategy using binary outcomes have been discussed previously.42
Briefly, an ideal meta-analysis should be performed using indi-
vidual patient data; however, individual patient data may not
always be available or practical to use. Therefore, the majority of
Figure 6 Meta-analysis of 5-year overall survival utilizing data from three studies comparing outcomes after transplantation and resection,
respectively, in early hepatocellular carcinoma (i.e. within the Milan Criteria) in patients with well-compensated cirrhosis, using an intention-
to-treat strategy. Odds ratios (ORs) for 5-year overall survival in the transplantation and resection subgroups were calculated using the
random-effects model. The diamond represents the overall effect; squares represent the effects for individual studies; bars indicate 95%
confidence intervals (CIs)
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meta-analyses, including that reported here, are performed using
summary data, which is a well-accepted form of analysis. The next
best option involves the performance of meta-analysis using
hazard ratios. Because the studies reviewed here usually did not
report hazard ratios, this method could not be utilized. The odds
ratio method, although not as accurate as methods using indi-
vidual patient data and hazard ratios, was found to be the most
feasible approach and was therefore used in the current study. The
calculation of odds ratios based on the Kaplan–Meier approach
can be criticized with reference to the issue of censored data; this
remains a weakness of the current study. Further, only one indexed
database (PubMed) was searched for literature and not all studies
may be indexed in one database. However, an extensive backward
search using cross-references and review articles was performed to
ensure the completeness of the literature search. Because of the
stringent inclusion and exclusion criteria applied in this study,
only a small number of studies were identified as suitable for
inclusion in the meta-analysis. These stringent criteria were nec-
essary because the topic is controversial in nature and the current
meta-analysis sought to resolve specific questions.Most of the data
from the reviewed studies were noted to be of insufficient quality
and were derived from small, single-institution studies that were
retrospective in nature. Similarly, most studies were carried out by
transplantation groups and may show a bias towards transplanta-
tion, and most studies were not of US origin and their results may
not be extrapolated to aUS population. Several other confounding
factors were not evaluated, such as the performance status, age,
eligibility and willingness for transplantation of patients. The
present meta-analysis does not address the issue of salvage liver
transplantation, the role of ablative therapies, the role of down-
staging, living donor liver transplantation, cost differences and
quality of life after transplantation and resection, respectively.
Neither did the current study address the issue of recurrence-free
survival as its aim was to look at difference in OS. Similarly, even
within studies that have performed an ITT analysis, regional varia-
tions in allocation times and organ availability may have some
bearing.Meta-analysis involves a statistical examination of a set of
scientific studies and is not actually scientific study in itself. The
results of the meta-analysis are as good as the studies it examines.
The aim of the presentmeta-analysis was to evaluate the published
evidence forOS after transplantation and resection, respectively, in
patients with early HCC and well-compensated cirrhosis. Despite
these limitations, the current study represents a comprehensive
analysis of comparisons of outcomes after transplantation and
resection, respectively. Its major strengths refer to its inclusion of
patients with matched extents of underlying liver disease, and its
emphasis on the use of ITT analysis.
In summary, although transplantation was noted to be superior
in some settings, this superiority was notmaintained in the critical
ITT analysis. The non-inferiority of either transplantation or
resection in the ITT analysis demonstrates that both will remain
viable treatment options for patients with early HCC and well-
compensated cirrhosis. The comprehensive analysis also under-
scores the lack of well-conducted comparative studies that include
patients who are matched equally for the extent of tumour and
underlying liver disease. Further well-designed studies are crucial
to address this controversial issue in order to establish optimal
strategies for the care of this group of patients.
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